Work

The differentiated SIRPα–IgG4 Fc fusion protein HCB101 in monotherapy and combination therapy.

Year: 2026

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.2655

Authors: Fangling Ning, Nicholas Iannotti, Wei-Hong Cheng, Ji Ma, Chia-Chi Lin, Ying Wang, Peter Mu-Hsin Chang, William Jeffery Edenfield, Wenyu Li, Yuping Sun, Tian Zhang, Jian Zhang, Hongyu Zhang, Peijian Peng, Langtian Abigail Yu, Fei Mo, David Sun, Alvin Luk

Institutions: Binzhou Medical University, Hematology Oncology Associates, Taipei Medical University-Shuang Ho Hospital, Shandong Tumor Hospital, National Taiwan University, Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine, National Yang Ming Chiao Tung University, Taipei Veterans General Hospital, Prisma Health, Guangdong Provincial People's Hospital, Harold C. Simmons Comprehensive Cancer Center, The University of Texas Southwestern Medical Center, Fudan University Shanghai Cancer Center, Sun Yat-sen University, Fifth Affiliated Hospital of Sun Yat-sen University

Language: English

Topic: Phagocytosis and Immune Regulation

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162570628

Cites:

Cited by:

Related to: